Development of Personalized Balanced Nutrition Concept Through an IT Platform
NCT05462444 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 450
Last updated 2023-02-08
Summary
By achieving effective cooperation between the Children's Hospital Srebrnjak (CHS), the Reference center for clinical allergology in children of the ministry of health, and IN2 Ltd., part of Constellation Software Inc., it is planned to develop an IT platform for the introduction of personalized balanced nutrition in kindergartens. The collected data which include the screening of the population, anthropometrical measurements, physical activity status, and medical examination, will be used to create a Registry of Allergies. Through the implementation of research activities, it is expected to develop an IT platform for personalized balanced nutrition of preschool children, which consists of a developed information system for continuous monitoring using a website and/or a mobile application.
Conditions
- Child Allergy
- Allergic Reaction
Interventions
- OTHER
-
Skin prick test
Skin prick test with a standard pallete of inhalational and nutritional allergens
Sponsors & Collaborators
-
IN2 Ltd.
collaborator UNKNOWN -
Children's Hospital Srebrnjak
lead OTHER
Eligibility
- Min Age
- 1 Year
- Max Age
- 6 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-03-29
- Primary Completion
- 2023-12-31
- Completion
- 2023-12-31
Countries
- Croatia
Study Locations
More Related Trials
-
The Influence of Nonspecific Immunostimulation on Changes in the Concentration of iNKT Cells
NCT04802616 ·Status: COMPLETED ·Phase: PHASE3
-
Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 6 Months to 11 Months
NCT00628108 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Lectranal® in Treatment of Seasonal Allergic Rhinitis Symptoms
NCT00460538 ·Status: COMPLETED ·Phase: PHASE4
-
Validation of an Allergic Rhinitis Control Test in Teenagers
NCT02818153 ·Status: UNKNOWN ·Phase: NA
-
Perennial Allergic Rhinitis In Pediatric Subjects
NCT00257595 ·Status: COMPLETED ·Phase: PHASE3
-
Molecular Basis of Food Allergy
NCT01832324 ·Status: ENROLLING_BY_INVITATION
-
Immune Nutrition in Pediatric Respiratory Allergy
NCT07308288 ·Status: COMPLETED ·Phase: NA
-
Study Of Perennial Allergic Rhinitis In Pediatrics
NCT00253058 ·Status: COMPLETED ·Phase: PHASE3
-
Study of an Investigational Nasal Aerosol or Placebo Nasal Aerosol in Children (Ages 6-11) With Seasonal Allergies
NCT01307319 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Compare the Efficacy of Levocetirizine to Placebo in Reducing Symptoms of Seasonal Allergic Rhinitis (SAR) in Sensitive Subjects Exposed to Ragweed Pollen
NCT00291642 ·Status: COMPLETED ·Phase: PHASE2
-
Compare the Efficacy of Levocetirizine to Montelukast in Reducing Symptoms of SAR in Sensitive Subjects Exposed to Ragweed Pollen
NCT00315523 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of a Sublingual Specific Immunotherapy With an Extract of a Six Grass Pollen Mixture
NCT00264459 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Levocetirizine 8 Weeks Prior and After the Onset of the Grass Pollen Season in Subjects With SAR
NCT00521040 ·Status: COMPLETED ·Phase: NA
-
App Based Study on the Symptoms of Patients With Allergic Rhinitis in the Pollen Season
NCT03112252 ·Status: COMPLETED
-
Intralymphatic Immunotherapy With Polvac Grass & Rye Allergen Extract
NCT05297760 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy and Safety of Levocetirizine and Fexofenadine in Reducing Symptoms of Seasonal Allergic Rhinitis
NCT00542607 ·Status: COMPLETED ·Phase: PHASE4
-
Tolerability of SLIT With LAIS® 2-Tree Allergoid Tablets
NCT02553590 ·Status: COMPLETED
-
Compare the Efficacy of Levocetirizine and Montelukast to Placebo in Reducing Seasonal Allergic Rhinitis (SAR) Symptoms in Ragweed Sensitive Subjects
NCT00295022 ·Status: COMPLETED ·Phase: PHASE4
-
Study Of Cutaneous Disease Accompanied With Pruritus In Pediatrics
NCT00257582 ·Status: COMPLETED ·Phase: PHASE3
-
Subcutaneous-Sublingual Immunotherapy With Depigmented and Polymerized Dermatophagoides Pteronyssinus Allergen Extract
NCT00622362 ·Status: TERMINATED ·Phase: PHASE2
-
The Prevalence and Clinical Characteristics of Children With Local Allergic Rhinitis
NCT02271620 ·Status: COMPLETED ·Phase: NA
-
Component Resolved Diagnostics (CRD) and mHealth for Pollen Allergy In Southern Europe.
NCT03636919 ·Status: COMPLETED
-
Efficacy and Safety of Lertal® as an add-on to Standard Therapy for Allergic Rhinoconjunctivitis in Pediatrics
NCT03365648 ·Status: COMPLETED ·Phase: NA
-
Exploration of the Optimal Dosage of Cetirizine in the Treatment of Allergic Diseases in Chinese Children
NCT06288334 ·Status: RECRUITING ·Phase: PHASE4
-
Study of Bronchodilation Effects of Cetirizine
NCT01781507 ·Status: COMPLETED ·Phase: PHASE4